Neurocrine Biosciences Appoints New Chief Medical Officer

, MT Newswires -  12:45 PM ET 4/4/2025 Company News

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

12:45 PM EDT, 04/04/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday it appointed Sanjay Keswani as chief medical officer, effective June 2.

He will succeed Eiry Roberts, who will transition to the role of a strategic advisor, the company said. Keswani was most recently the president and CEO of ImmunoBrain.

Price: 95.40, Change: -7.49, Percent Change: -7.28

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.